IP Library Granted Patent US 12,503,694
Granted Patent B2
US 12,503,694 · App. 19/180,024 · Granted Dec 23, 2025

Systems and methods for biomolecule retention

Inventors: Torri Elise Rinker (San Francisco, CA); Christina Inman (San Leandro, CA); Steven Tan (San Mateo, CA); Pengyu Hao (Belmont, CA); Elvis Ikwa (San Leandro, CA); Pierre Indermuhle (Berkeley, CA); Parag Mallick (San Mateo, CA); Tural Aksel (Redwood City, CA); Stephen Hendricks (Los Gatos, CA); Sadie Ingle (Suttons Bay, MI)
Assignee: Nautilus Subsidiary, Inc.
C12N15/1093B01J19/0046B82Y5/00C12Q1/6804C12Q1/6837B01J2219/0061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,503,694
App. No.
19/180,024
Granted
Dec 23, 2025
Kind
B2
Abstract

Compositions, systems, and methods for the display of analytes such as biomolecules are described. Display of analytes is achieved by coupling of the analytes to displaying molecules that are configured to associate with surfaces or interfaces. Arrays of analytes may be formed from the described systems for utilization in assays and other methods.

Claims (42)

1 . A method, comprising:

a) providing a solid support comprising a plurality of sites, wherein each individual site of the plurality of sites comprises:

i) only one particle coupled to the individual site; and

ii) only one polypeptide of interest attached to the only one particle;

b) delivering binding reagents to the solid support, thereby coupling binding reagents to polypeptides of interest at sites of the plurality of sites;

c) repeating step b) using second binding reagents instead of the binding reagents, wherein the second binding reagents are different from the binding reagents;

d) for each individual site, detecting presence or absence of coupling of each individual binding reagent and second binding reagent to the polypeptide of interest; and

e) based upon presence or absence of coupling of each individual binding reagent and second binding reagent to the polypeptide of interest, characterizing the polypeptide of interest at each individual site of the plurality of sites.

2 . The method of claim 1 , wherein the only one particle is coupled to the individual site by nucleic acid hybridization.

3 . The method of claim 2 , wherein the only one particle comprises one or more oligonucleotides, wherein the individual site comprises one or more complementary oligonucleotides, and wherein the one or more oligonucleotides of the particle are hybridized to the one or more complementary oligonucleotides of the individual site.

4 . The method of claim 1 , wherein the particle comprises a surface-interacting moiety.

5 . The method of claim 4 , wherein the surface-interacting moiety comprises a polymer nanoparticle.

6 . The method of claim 5 , wherein the polymer nanoparticle comprises a nucleic acid nanoparticle.

7 . The method of claim 1 , wherein the binding reagents comprise affinity reagents.

8 . The method of claim 7 , wherein an affinity reagent of the affinity reagents comprises an aptamer.

9 . The method of claim 7 , wherein an affinity reagent of the affinity reagents comprises an antibody or an antibody fragment.

10 . The method of claim 7 , wherein coupling binding reagents to polypeptides of interest comprises coupling an affinity reagent to an epitope of the polypeptide of interest.

11 . The method of claim 7 , wherein coupling binding reagents to polypeptides of interest comprises coupling an affinity reagent to a modified N-terminal amino acid of the polypeptide of interest.

12 . The method of claim 1 , wherein a polypeptide of interest has a full-length primary amino acid structure.

13 . The method of claim 1 , wherein a polypeptide of interest is a fragment of a full-length primary amino acid structure.

14 . The method of claim 1 , wherein providing the solid support comprises providing the solid support comprising a first species of polypeptide and a second species of polypeptide.

15 . The method of claim 14 , wherein the first species of polypeptide and the second species of polypeptide have a dynamic range of at least 10 4 .

16 . The method of claim 15 , wherein characterizing the polypeptide of interest at each individual site of the plurality of sites comprises identifying a polypeptide of the first species of polypeptide and a polypeptide of the second species of polypeptide.

17 . The method of claim 1 , wherein providing the solid support comprises providing the solid support comprising at least 1000 unique polypeptide species of interest.

18 . The method of claim 17 , wherein characterizing the polypeptide of interest at each individual site of the plurality of sites comprises identifying the 1000 unique polypeptide species of interest.

19 . The method of claim 1 , wherein providing the solid support comprises providing the solid support comprising at least 25% of polypeptide species of a proteome.

20 . The method of claim 19 , wherein characterizing the polypeptide of interest at each individual site of the plurality of sites comprises identifying the at least 25% of polypeptide species of the proteome.

21 . The method of claim 1 , wherein detecting presence or absence of coupling of each individual binding reagent to the polypeptide of interest comprises detecting presence or absence of fluorescent signals at an address of the site comprising the polypeptide of interest.

22 . The method of claim 21 , wherein detecting presence or absence of fluorescent signals at an address of the site comprising the polypeptide of interest occurs for each instance of delivering binding reagents to the solid support.

23 . The method of claim 1 , wherein detecting presence or absence of coupling of each individual binding reagent to the polypeptide of interest comprises detecting presence or absence of a nucleic acid tag.

24 . The method of claim 1 , wherein characterizing the polypeptide of interest comprises identifying a species of the polypeptide of interest.

25 . The method of claim 1 , wherein characterizing the polypeptide of interest comprises identifying an amino acid sequence of the polypeptide of interest.

26 . The method of claim 1 , wherein characterizing the polypeptide of interest comprises identifying a proteoform of the polypeptide of interest.

27 . The method of claim 1 , wherein the polypeptide of interest is attached to the particle by a linking moiety.

28 . The method of claim 27 , wherein the linking moiety provides a separation gap of at least 10 nanometers (nm) between the polypeptide of interest and the solid support.

29 . The method of claim 1 , further comprising removing the binding reagents from the polypeptides of interest.

30 . The method of claim 27 , wherein the linking moiety comprises a double-stranded nucleic acid.

31 . The method of claim 27 , wherein the particle comprises a first face and a second face, wherein the first face is attached to the solid support, wherein the second face is oriented away from the solid support, and wherein the second face comprises the linking moiety.

32 . The method of claim 1 , wherein the plurality of sites is provided in a plurality of wells.

33 . The method of claim 32 , wherein each well of the plurality of wells comprises only one site of the plurality of sites.

34 . The method of claim 1 , wherein each binding reagent of the binding reagents binds to a first set of two or more structurally dissimilar polypeptides.

35 . The method of claim 34 , wherein each binding reagent of the second binding reagents binds to a second set of two or more structurally dissimilar polypeptides, wherein the first set of two or more structurally dissimilar polypeptides differs from the second set of two or more structurally dissimilar polypeptides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: HAO, PENGYU; IKWA, ELVIS; INDERMUHLE, PIERRE; INMAN, CHRISTINA; MALLICK, PARAG; RINKER, TORRI ELISE; TAN, STEVEN; AKSEL, TURAL; HENDRICKS, STEPHEN; INGLE, SADIE
To: NAUTILUS SUBSIDIARY, INC.
Reel/Frame 072036/0905 →
Continuity (8)
Continuation 18770462 · Jul 11, 2024
Continuation 18416639 · Jan 18, 2024
Continuation 18361731 · Jul 28, 2023
Continuation 18050732 · Oct 28, 2022
Continuation 17692035 · Mar 10, 2022
Provisional Application 63256761 · Oct 18, 2021
Provisional Application 63159500 · Mar 11, 2021
Related Publication 20250290064A1 · Sep 18, 2025
References Cited (193)
US 5324633A · Fodor et al. · 1994 [cited by applicant]
US 5695934A · Brenner · 1997 [cited by applicant]
US 5863722A · Brenner · 1999 [cited by applicant]
US 5888737A · Dubridge et al. · 1999 [cited by applicant]
US 5919626A · Shi et al. · 1999 [cited by applicant]
US 6140489A · Brenner · 2000 [cited by applicant]
US 6175002B1 · Dubridge et al. · 2001 [cited by applicant]
US 6255469B1 · Seeman et al. · 2001 [cited by applicant]
US 6391625B1 · Park et al. · 2002 [cited by applicant]
US 6589726B1 · Butler et al. · 2003 [cited by applicant]
US 6610482B1 · Fodor et al. · 2003 [cited by applicant]
US 6737236B1 · Pieken et al. · 2004 [cited by applicant]
US 6806361B1 · Kajisa et al. · 2004 [cited by applicant]
US 6824866B1 · Glazer et al. · 2004 [cited by applicant]
US 7122482B2 · Xu et al. · 2006 [cited by applicant]
US 7148058B2 · Charych et al. · 2006 [cited by applicant]
US 7158224B2 · Montagu · 2007 [cited by applicant]
US 7181122B1 · Levene et al. · 2007 [cited by applicant]
US 7183054B2 · Myers et al. · 2007 [cited by applicant]
US 7259258B2 · Kozlov et al. · 2007 [cited by applicant]
US 7302146B2 · Turner et al. · 2007 [cited by applicant]
US 7306904B2 · Landegren et al. · 2007 [cited by applicant]
US 7313308B2 · Turner et al. · 2007 [cited by applicant]
US 7329860B2 · Feng et al. · 2008 [cited by applicant]
US 7351528B2 · Landegren · 2008 [cited by applicant]
US 7375234B2 · Sharpless et al. · 2008 [cited by applicant]
US 7427678B2 · Pieken et al. · 2008 [cited by applicant]
US 7598363B2 · Seeman et al. · 2009 [cited by applicant]
US 7635562B2 · Harris et al. · 2009 [cited by applicant]
US 7763736B2 · Sharpless et al. · 2010 [cited by applicant]
US 7794799B1 · Kim et al. · 2010 [cited by applicant]
US 7842793B2 · Rothemund · 2010 [cited by applicant]
US 7855054B2 · Schneider et al. · 2010 [cited by applicant]
US 7955837B2 · Pawlak et al. · 2011 [cited by applicant]
US 7964356B2 · Zichi et al. · 2011 [cited by applicant]
US 8013134B2 · Fredriksson · 2011 [cited by applicant]
US 8133719B2 · Drmanac et al. · 2012 [cited by applicant]
US 8148264B2 · Henry et al. · 2012 [cited by applicant]
US 8222047B2 · Duffy et al. · 2012 [cited by applicant]
US 8236574B2 · Duffy et al. · 2012 [cited by applicant]
US 8268554B2 · Schallmeiner · 2012 [cited by applicant]
US 8404830B2 · Zichi et al. · 2013 [cited by applicant]
US 8415171B2 · Rissin et al. · 2013 [cited by applicant]
US 8445194B2 · Drmanac et al. · 2013 [cited by applicant]
US 8501923B2 · Rothemund · 2013 [cited by applicant]
US 8685894B2 · Chaput et al. · 2014 [cited by applicant]
US 8765359B2 · Fernandez et al. · 2014 [cited by applicant]
US 8798414B2 · Quan et al. · 2014 [cited by applicant]
US 8877516B2 · Lin et al. · 2014 [cited by applicant]
US 8945811B2 · True · 2015 [cited by applicant]
US 8945830B2 · Heil et al. · 2015 [cited by applicant]
US 8951781B2 · Williamson et al. · 2015 [cited by applicant]
US 8975026B2 · Zichi et al. · 2015 [cited by applicant]
US 8975388B2 · Zichi et al. · 2015 [cited by applicant]
US 9163056B2 · Rohloff et al. · 2015 [cited by applicant]
US 9164053B2 · Collins et al. · 2015 [cited by applicant]
US 9193996B2 · Buermann et al. · 2015 [cited by applicant]
US 9275871B2 · Sandhu · 2016 [cited by applicant]
US 9330932B1 · Sills et al. · 2016 [cited by applicant]
US 9340416B2 · Maune et al. · 2016 [cited by applicant]
US 9347829B2 · Loncar et al. · 2016 [cited by applicant]
US 9395359B2 · Walt et al. · 2016 [cited by applicant]
US 9399795B2 · Chee et al. · 2016 [cited by applicant]
US 9404919B2 · Schneider et al. · 2016 [cited by applicant]
US 9410887B2 · Walavalkar et al. · 2016 [cited by applicant]
US 9466504B1 · Sills et al. · 2016 [cited by applicant]
US 9551663B2 · Rissin et al. · 2017 [cited by applicant]
US 9556360B2 · Mcgall et al. · 2017 [cited by applicant]
US 9606058B2 · Rothberg et al. · 2017 [cited by applicant]
US 9625469B2 · Marcotte et al. · 2017 [cited by applicant]
US 9678012B2 · Rothberg et al. · 2017 [cited by applicant]
US 9678068B2 · Duffy et al. · 2017 [cited by applicant]
US 9717685B2 · Shih et al. · 2017 [cited by applicant]
US 9777315B2 · Fredriksson et al. · 2017 [cited by applicant]
US 9796749B2 · Yin et al. · 2017 [cited by applicant]
US 9829456B1 · Jin et al. · 2017 [cited by applicant]
US 9881786B2 · Sills et al. · 2018 [cited by applicant]
US 9921157B2 · Rothberg et al. · 2018 [cited by applicant]
US 9926566B2 · Ochsner et al. · 2018 [cited by applicant]
US 9938314B2 · Rohloff et al. · 2018 [cited by applicant]
US 9975916B2 · Yin et al. · 2018 [cited by applicant]
US 9987609B2 · Walavalkar et al. · 2018 [cited by applicant]
US 10036064B2 · Merriman et al. · 2018 [cited by applicant]
US 10099920B2 · Shen et al. · 2018 [cited by applicant]
US 10221207B2 · Rohloff et al. · 2019 [cited by applicant]
US 10221421B2 · Jarvis et al. · 2019 [cited by applicant]
US 10239908B2 · Rohloff et al. · 2019 [cited by applicant]
US 10316321B2 · Zichi et al. · 2019 [cited by applicant]
US 10392621B2 · Ochsner et al. · 2019 [cited by applicant]
US 10473654B1 · Mallick · 2019 [cited by applicant]
US 10513535B2 · He et al. · 2019 [cited by applicant]
US 10545153B2 · Marcotte et al. · 2020 [cited by applicant]
US 10550145B2 · Han et al. · 2020 [cited by applicant]
US 10604543B2 · Yin et al. · 2020 [cited by applicant]
US 10605730B2 · Rothberg et al. · 2020 [cited by applicant]
US 10646505B2 · Schulz et al. · 2020 [cited by applicant]
US 10712274B2 · Rothberg et al. · 2020 [cited by applicant]
US 10741382B2 · Sills et al. · 2020 [cited by applicant]
US 10775305B2 · Rothberg et al. · 2020 [cited by applicant]
US 10845308B2 · Rothberg et al. · 2020 [cited by applicant]
US 10895534B2 · Finkelstein et al. · 2021 [cited by applicant]
US 11001606B2 · Tikhomirov et al. · 2021 [cited by applicant]
US 11060135B2 · Bowen et al. · 2021 [cited by applicant]
US 11125748B2 · Gopinath et al. · 2021 [cited by applicant]
US 11162192B2 · Gopinath et al. · 2021 [cited by applicant]
US 11192083B2 · Kraft et al. · 2021 [cited by applicant]
US 11203612B2 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 11235972B2 · Gopalkrishnan et al. · 2022 [cited by applicant]
US 11760997B2 · Aksel et al. · 2023 [cited by applicant]
US 20040209383A1 · Yin et al. · 2004 [cited by applicant]
US 20050054118A1 · Lebrun · 2005 [cited by applicant]
US 20050095577A1 · Yang et al. · 2005 [cited by applicant]
US 20050287523A1 · Letant et al. · 2005 [cited by applicant]
US 20060035220A1 · Tashiro et al. · 2006 [cited by applicant]
US 20070007991A1 · Lee et al. · 2007 [cited by applicant]
US 20090018028A1 · Lindsay et al. · 2009 [cited by applicant]
US 20090026082A1 · Rothberg et al. · 2009 [cited by applicant]
US 20090127589A1 · Rothberg et al. · 2009 [cited by applicant]
US 20090247414A1 · Obradovic et al. · 2009 [cited by applicant]
US 20100069621A1 · Maune et al. · 2010 [cited by applicant]
US 20100111768A1 · Banerjee et al. · 2010 [cited by applicant]
US 20100137143A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100282617A1 · Rothberg et al. · 2010 [cited by applicant]
US 20130116153A1 · Bowen et al. · 2013 [cited by applicant]
US 20150004193A1 · Chang et al. · 2015 [cited by applicant]
US 20160060687A1 · Zhu et al. · 2016 [cited by applicant]
US 20160102344A1 · Niemeyer et al. · 2016 [cited by applicant]
US 20170240962A1 · Merriman et al. · 2017 [cited by applicant]
US 20170327888A1 · Ong et al. · 2017 [cited by applicant]
US 20180044663A1 · Yan · 2018 [cited by applicant]
US 20180051316A1 · Collins et al. · 2018 [cited by applicant]
US 20180112265A1 · Boyanov et al. · 2018 [cited by applicant]
US 20180148514A1 · Williams · 2018 [cited by applicant]
US 20180155773A1 · Gunderson et al. · 2018 [cited by applicant]
US 20180305727A1 · Merriman et al. · 2018 [cited by applicant]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20190195869A1 · Fan et al. · 2019 [cited by applicant]
US 20190323002A1 · Gopinath et al. · 2019 [cited by applicant]
US 20200082914A1 · Patel et al. · 2020 [cited by applicant]
US 20200090785A1 · Patel et al. · 2020 [cited by applicant]
US 20200286584A9 · Patel et al. · 2020 [cited by applicant]
US 20200289658A1 · Stephanopoulos et al. · 2020 [cited by applicant]
US 20200318101A1 · Mallick et al. · 2020 [cited by applicant]
US 20200348307A1 · Beierle et al. · 2020 [cited by applicant]
US 20200348308A1 · Chee et al. · 2020 [cited by applicant]
US 20200354777A1 · Grabmayr et al. · 2020 [cited by applicant]
US 20210032775A1 · Gopinath et al. · 2021 [cited by applicant]
US 20210101930A1 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 20210239705A1 · Mallick · 2021 [cited by applicant]
EP 1105529B2 · 2013 [cited by applicant]
EP 3699142A1 · 2020 [cited by applicant]
EP 3498865B1 · 2020 [cited by applicant]
WO 2005065814A1 · 2005 [cited by applicant]
WO 2007123744A2 · 2007 [cited by applicant]
WO 2019195633A1 · 2019 [cited by applicant]
WO 2019211631A1 · 2019 [cited by applicant]
WO 2019236749A2 · 2019 [cited by applicant]
WO 2020106889A1 · 2020 [cited by applicant]
WO 2020176793A1 · 2020 [cited by applicant]
WO 2020223368A1 · 2020 [cited by applicant]
WO 2020254684A1 · 2020 [cited by applicant]
WO 2021087402A1 · 2021 [cited by applicant]
Aebersold et al. “How many human proteoforms are there?” Nature chemical biology 14.3 (2018): 206-214. [cited by applicant]
Anderson et al. “The human plasma proteome: history, character, and diagnostic prospects.” Molecular & cellular proteomics 1.11 (2002): 845-867. [cited by applicant]
Angelin et al. “Multiscale origami structures as interface for cells.” Angewandte Chemie International Edition 54.52 (2015): 15813-15817. [cited by applicant]
Chang, Jui Yoa. “A novel Edman-type degradation: direct formation of the thiohydantoin ring in alkaline solution by reaction of Edman-type reagents with N-monomethyl amino acids.” FEBS letters 91.1 (1978): 63-68. [cited by applicant]
Cutler et al. “Spherical nucleic acids.” Journal of the American Chemical Society 134.3 (2012): 1376-1391. [cited by applicant]
Derr et al. “Tug-of-war in motor protein ensembles revealed with a programmable DNA origami scaffold.” Science 338.6107 (2012): 662-665. [cited by applicant]
Drmanac et al. “Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.” Science 327.5961 (2010): 78-81. [cited by applicant]
Gheorghe et al. “Deacetylation and internal cleavage of polypeptides for N-terminal sequence analysis.” Methods in Protein Structure Analysis. Boston, MA: Springer US, 1995. 81-86. [cited by applicant]
Gopinath et al. “Optimized assembly and covalent coupling of single-molecule DNA origami nanoarrays.” ACS nano 8.12 (2014): 12030-12040. [cited by applicant]
Ho et al. “Unification of protein abundance datasets yields a quantitative [cited by applicant]
Hookway et al. “Aggregate formation and suspension culture of human pluripotent stem cells and differentiated progeny.” Methods 101 (2016): 11-20. [cited by applicant]
International Search Report and Written Opinion in PCT/US2022/019831, mailed Jul. 6, 2022, 12 pages. [cited by applicant]
Jaekel et al. “Manipulating enzymes properties with DNA nanostructures.” Molecules 24.20 (2019): 3694, 1-24. [cited by applicant]
Jensen et al. “Nanoengineered Bioplatforms Based on DNA Origami [Point of View].” Proceedings of the IEEE 102.7 (2014): 1046-1049. [cited by applicant]
Kolb et al. “Click chemistry: diverse chemical function from a few good reactions.” Angewandte Chemie International Edition 40.11 (2001): 2004-2021. [cited by applicant]
Rissin et al. “Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.” Nature biotechnology 28.6 (2010): 595-599. [cited by applicant]
Rothemund, Paul W.K. “Folding DNA to create nanoscale shapes and patterns.” Nature 440.7082 (2006): 297-302. [cited by applicant]
Spicer et al. “Achieving controlled biomolecule biomaterial conjugation.” Chemical reviews 118.16 (2018): 7702-7743. [cited by applicant]
Stawicki et al. “Modular fluorescent nanoparticle DNA probes for detection of peptides and proteins.” Scientific Reports 11.1 (2021): 19921, 1-15. [cited by applicant]
Swaminathan et al. “Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures.” Nature biotechnology 36.11 (2018): 1076-1082. [cited by applicant]
U.S. Appl. No. 63/139,818, filed Jan. 21, 2021, 197 pages. [cited by applicant]
Vauquelin et al. “Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.” British journal of pharmacology 168.8 (2013): 1771-1785. [cited by applicant]
Weinrich et al. “Applications of protein biochips in biomedical and biotechnological research.” Angewandte Chemie International Edition 48.42 (2009): 7744-7751. [cited by applicant]
Wisniewski et al. “A “proteomic ruler” for protein copy number and concentration estimation without spike-in standards.” Molecular & cellular proteomics 13.12 (2014): 3497-3506. [cited by applicant]
Xin et al. “Self-assembly of highly ordered DNA origami lattices at solid-liquid interfaces by controlling cation binding and exchange.” Nano Research 13 (2020): 3142-3150. [cited by applicant]
Xu et al. “Super-resolution Geometric Barcoding for Multiplexed miRNA Profiling.” Angewandte Chemie International Edition 57.43 (2018): 14075-14079. [cited by applicant]
Xu et al. “Supporting Information—Super-resolution Geometric Barcoding for Multiplexed miRNA Profiling.” Angewandte Chemie International Edition 57.43 (2018): 1-33. [cited by applicant]
Yang et al. “Programmable Site-Specific Functionalization of DNA Origami with Polynucleotide Brushes.” Angewandte Chemie International Edition 60.43 (2021): 23241-23247. [cited by applicant]
Zakeri et al. “Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin.” Proceedings of the National Academy of Sciences 109.12 (2012): E690-E697. [cited by applicant]
Zhang et al. “Capturing transient antibody conformations with DNA origami epitopes.” Nature communications 11.1 (2020): 3114, 1-9. [cited by applicant]
Zhao et al. “Organizing DNA origami tiles into larger structures using preformed scaffold frames.” Nano letters 11.7 (2011): 2997-3002. [cited by applicant]